​

89bio (ETNB) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

89bio Revenue Highlights

00

89bio Revenue by Period

89bio Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31--

89bio generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

89bio Revenue by Quarter

DateRevenueChange
2024-09-30-100.00%
2024-06-30-100.00%
2024-03-31--100.00%
2023-12-31$234.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30--

89bio generated - in revenue during Q3 2024, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.

89bio Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
TGTXTG Therapeutics$233.66M$83.88M
ACLXArcellx$110.32M$26.03M
HOOKHOOKIPA Pharma$20.13M-
MREOMereo BioPharma Group$10.00M-
STOKStoke Therapeutics$8.78M$4.89M
PLRXPliant Therapeutics$1.58M-
XFORX4 Pharmaceuticals-$560.00K
VKTXViking Therapeutics--
DAWNDay One Biopharmaceuticals-$20.07M
ABOSAcumen Pharmaceuticals--
INZYInozyme Pharma--
MDGLMadrigal Pharmaceuticals-$62.17M
TERNTerns Pharmaceuticals--
ETNB89bio--
AKROAkero Therapeutics--
HEPAHepion Pharmaceuticals--

ETNB Revenue FAQ

What is 89bio’s yearly revenue?

89bio's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. ETNB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.

What is 89bio’s quarterly revenue?

89bio's quarterly revenue for Q3 2024 was $0, a 100.00% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). ETNB's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is 89bio’s revenue growth rate?

89bio's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.